Pharma scandals spawn investor lawsuits at KaloBios, Sequoia

Angry investors of KaloBios and Sequoia Fund are taking their pharma grievances to the courts. Shareholders at KaloBios--formerly led by pharma bad boy Martin Shkreli--are suing to get back the $5.4 million they had invested just hours before his arrest, Reuters reports, while investors who claim Sequoia recklessly took a huge stake in Valeant ($VRX) are suing that fund. Report | Report

Suggested Articles

Johnson & Johnson faces a litany of problems, but executives are clearly not concerned—at least not about the company's short-term fortunes.

This week, Goldman Sachs resurrected a burning question: How can pharma companies profit from curing patients with one-time gene and cell therapies?

CMS has determined how it'll pay for Gilead's CAR-T cancer therapy, Yescarta, for outpatient use, but hasn't yet decided on Gilead's…